Skip to main content
Caplight Logo









Phil Rivers Technology

Phil Rivers Technology

Private
BeijingHealthcare & Life Scienceshttps://www.philrivers.com/

Last Round

Series A

Extension

Aug 5, 2026

Total Funding Raised

$58.9M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Phil Rivers Technology is a biotechnology company that leverages artificial intelligence and computational medicine to accelerate drug discovery and clinical development.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Revenue Share

AI Layer

Application

Keywords

drug discoverycomputational medicinein silico drug discoveryAI drug discoverydigital twinAI for scienceAI4Sclinical trial simulationbiotech AIgenomic analysisdrug target identificationvirtual clinical trialsprecision medicinebiomedical knowledge graphoncology R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Phil Rivers Technology Comparables

Compare Phil Rivers Technology with similar companies based on industry and business-model similarity.

Phil Rivers Technology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
InSilicoTrials Technologies
83%
VeriSIM Life
81%
Beyang Therapeutics Co., Ltd.
81%

Phil Rivers Technology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionAug 5, 2026
Series A ExtensionDec 16, 2025
Series AJul 7, 2022

Phil Rivers Technology Investors

Notable investors and investment history

Phil Rivers Technology investors
InvestorRounds
CAS StarSeries A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 5, 2026

    $30M round led by CAS Star and Sansure Biotech Inc.

  • Dec 16, 2025

    $14M round with ChemPartner PharmaTech participating.

Phil Rivers Technology Filings

Explore SEC and related filing metadata, where available.

Phil Rivers Technology filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Phil Rivers Technology's valuation, stock price, and market status.

Is Phil Rivers Technology a public or private company?

Phil Rivers Technology is a private company.

What is the current stock price of Phil Rivers Technology?

Phil Rivers Technology is a private company with no public stock price. Caplight tracks Phil Rivers Technology's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Phil Rivers Technology worth (valuation)?

Valuation information for Phil Rivers Technology is not publicly available.

Can I buy Phil Rivers Technology stock?

Phil Rivers Technology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Phil Rivers Technology's last funding round?

Phil Rivers Technology's most recent funding round was Series A Extension on August 5, 2026.

Who are the main investors in Phil Rivers Technology?

Key investors in Phil Rivers Technology include CAS Star.

Will Phil Rivers Technology IPO soon?

No public IPO plans have been announced for Phil Rivers Technology.

How can I track Phil Rivers Technology secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Phil Rivers Technology's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBeijing
Year Founded2015
Last FundingAug 5, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?